The horseshoe crab has been scuttling in the ocean and tidal pools for more than 400 million years, playing a vital role in the East Coast ecosystem along with being a prized item for fishing bait and medical research.

Its blue blood is harvested for medical researchers and used by drug and medical device makers to test for dangerous impurities in vaccines, prosthetics and intravenous drugs. The crabs are used by fishing crews as bait to catch eels and sea snails. And their eggs are a critical food for a declining subspecies of bird called the red knot – a rust-colored, migratory shorebird listed as threatened under the Endangered Species Act.

The competing interests have set up a clash among researchers, fishing crews and environmentalists over new protections designed to keep more of the crabs in the environment. The animals are drained of some of their blood and returned to the shore, but many die from the bleeding. And a drive to create synthetic alternatives has yet to succeed in phasing out the crabs from use.

Recent revisions to guidelines for handling the animals should keep more alive through the process, regulators said. The animals — not really true crabs but rather more closely related to land-dwelling invertebrates such as spiders and scorpions — are declining in some of their East Coast range.

"They were here before the dinosaurs," said Glenn Gauvry, president of Ecological Research & Development Group, a Delaware-based nonprofit that advocates for horseshoe crab conservation. "And they’re having problems because the new kids on the block, us, haven’t learned to appreciate the elders."

The harvest of horseshoe crabs has emerged as a critical issue for conservationists in recent years because of the red knot. The birds, which migrate some 19,000 miles (30,577 kilometers) roundtrip from South America to Canada and must stop to eat along the way, need stronger protection of horseshoe crabs to survive, said Bethany Kraft, senior director for coastal conservation with the Audubon Society.

Kraft and other wildlife advocates said the fact the guidelines for handling crabs are voluntary and not mandatory leaves the red knot at risk.

“Making sure there is enough to fuel these birds on this massive, insanely long flight is just critical,” Kraft said. “There's very clear linkage between horseshoe crabs and the survival of the red knot in the coming decades.”

The horseshoe crabs are valuable because their blood can be manufactured into limulus amebocyte lysate, or LAL, that is used to detect pathogens in indispensable medicines such as injectable antibiotics. The crabs are collected by fishermen by hand or via trawlers for use by biomedical companies, then their blood is separated and proteins within their white blood cells are processed. It takes dozens of the crabs to produce enough blood to fill a single glass tube with its blood, which contains immune cells sensitive to bacteria.

There are only five federally licensed manufacturers on the East Coast that process horseshoe crab blood. The blood is often described by activist groups as worth $15,000 a quart (liter), though some members of the industry say that figure is impossible to verify.

Regulators estimate about 15% of the crabs die in the bleeding process. In 2021, that meant about 112,000 crabs died, said Caitlin Starks, a senior fishery management plan coordinator with the Atlantic States Marine Fisheries Commission. The bait fishery for horseshoe crabs, which are used as bait for eels and sea snails, killed more than six times that, she said.

Still, the fisheries commission in May approved new best management practices for the biomedical industry's harvesting and handling of the crabs. Those include minimizing exposure to sunlight and keeping crabs cool and moist, Starks said.

“The goal is to give the crabs that are bled a better chance of surviving and contributing to the ecosystem after they are released,” she said.

That's exactly what the new guidelines will do, said Nora Blair, quality operations manager with Charles River Laboratories, one of the companies that manufactures LAL from horseshoe crab blood. Blair was a member of a working group that crafted the updated guidelines alongside other industry members, conservationists, fishery managers, fishermen and others.

Blair said the industry is working toward synthetic alternatives — an outcome conservationists have been pushing for years. Lonza, a Switzerland-based company that is one of the LAL manufacturers, offers animal-free testing solution, and the company has touted it as a way to test for toxins while protecting natural resources, said Victoria Morgan, a spokesperson for the company.

However, for now the wild harvest of horseshoe crabs remains critically important to drug safety, Blair said.

“The critical role of horseshoe crab in the biopharmaceutical supply chain and coastal ecosystem makes their conservation imperative,” he said.

The Atlantic horseshoe crab, the species harvested on the East Coast, ranges from the Gulf of Maine to Florida. The International Union for Conservation of Nature lists the species as being “vulnerable” based on a 2016 assessment.

One of the most important ecosystems for horseshoe crabs is the Delaware Bay, an estuary of the Delaware River between Delaware and New Jersey. The bay is where the crabs breed and the red knots feed.

The density of horseshoe crab eggs in the bay is nowhere near what it was in the 1990s, said Lawrence Niles, an independent wildlife biologist who once headed New Jersey's state endangered species program. Meanwhile, the population of the rufa red knot, the threatened subspecies, has declined by 75% since the 1980s, according to the National Park Service.

The birds need meaningful protection of horseshoe crab eggs to be able to recover, Niles said. He tracks the health of red knots and horseshoe crabs and has organized a group called Horseshoe Crab Recovery Coalition to advocate for conservation measures.

Niles and volunteers he organizes have been counting the horseshoe crab eggs since the 1980s and tagging birds since the 1990s. In mid-June, as he was wrapping up this year's tracking in southern New Jersey, he described the eggs as “good and consistent” through the month.

“What we want is the harvest to stop, the killing to stop, and let the stock rebuild to its carrying capacity,” Niles said.

The horseshoe crabs have been harvested for use as bait and medicine from Florida to Maine over the years, though the largest harvests are in Maryland, Delaware, Massachusetts and Virginia. According to federal fishery statistics, the crabs were worth about $1.1 million in total at the docks in 2021.

That figure is dwarfed by seafood species such as lobsters and scallops, which are routinely worth hundreds of millions of dollars. However, horseshoe crab fishers are dedicated stewards of a fishery that supplies a vital product, said George Topping, a Maryland fisherman.

“Everything you do in life comes from horseshoe crab blood. Vaccines, antibiotics,” he said. “The horseshoe crab stocks are healthy."

Share:
More In Science
New Tech Firm PulseForge Looks to Reduce Emissions From Manufacturing
Stan Farnsworth, chief marketing officer at PulseForge, joined Cheddar to talk about his company's debut at CES 2022 and how it plans to innovate the sustainable tech manufacturing space. PulseForge is bringing a new approach to industrial thermal processing, which contributes to 30 percent of global greenhouse gas emissions, according to Farnsworth. "By using 85 percent less energy in the processing of materials through a variety of manufacturing processes, we can make a direct impact in reducing carbon output and reducing carbon footprint associated with manufacturing," he said.
Vaccination Mandate for Crossing U.S. Border to Go Into Effect
The U.S. will be implementing a vaccine mandate for all people entering through its land borders, removing exemptions for "essential" travelers such as truckers, students, and business people. While the Canadian Trucking Alliance argues that the new, stricter rule might exacerbate ongoing auto supply chain issues, some health experts see the potential for helping curb the ongoing pandemic. Anthony Santella, a professor of health administration at the University of New Haven, joined Cheddar to give his take on the updated border crossing restriction. "We can't just focus on one type of travel. We need to ensure that it's clear and consistent across all types of travel," Santella said.
Space VIP Announces NYC's Space Prize Challenge
To encourage and inspire young women to pursue careers in STEAM, or science, technology, engineering, arts, and math, Space VIP has officially launched its New York Space Prize Challenge. Young women enrolled in the public school system within New York's five boroughs and are between the ages of 15 to 18 are welcomed to participate. Executive Director of Space Prize, Kim Macharia, joined Cheddar to discuss more.
Behind Australian Judges Ruling for Allowing Novak Djokovic Deportation
The drama surrounding tennis star Novak Djokovic continues after he was deported from Australia over the weekend due to the nation's COVID-19 vaccine requirements. Djokovic was forced to leave the country on the eve of what was to be his first match in defense of his Australian Open title after three judges ruled in favor of his removal and revealed their reasoning for doing so. Adding to his woes, a law recently passed in France is putting his chances of defending his French Open title in jeopardy. The director of Marist's Center for Sports Communication, Jane McManus, joined Cheddar to discuss the ongoing fallout.
Dept. Of Agriculture 10-Year Plan To Combat Wildfires
The Department of Agriculture has officially unveiled its plan to fight catastrophic wildfires that have devastated parts of the West in the last few years. The department, along with the Forest Service will work to significantly increase fuels and forest health treatments to address the escalating crisis of wildfire danger. Executive Editor of Cipher, a publication by Breakthrough Energy, Amy Harder, joined Cheddar to discuss more.
Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD
Brainsway, the medical device company that developed deep TMS, has been conducting clinical trials of the treatment in various psychiatric, neurological, and addiction disorders. Their most recent research suggests that deep TMS is an effective treatment for OCD. Christopher Von Jako, president and chief executive officer of Brainsway, joins Cheddar News to discuss.
Load More